Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How good is our genome?

Jean-Claude Weill1, Miroslav Radman

  • 1Faculte de Medecine Necker Enfants-Malades, Université de Paris-V, Paris, France.. weill@necker.fr

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|April 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections.

Cell·2026
Same author

Contact-dependent regulation of UV-B/C-induced cell fate by neighboring intact cells.

Journal of photochemistry and photobiology. B, Biology·2026
Same author

Oxidative protein damage negatively affects protein-protein interaction: The case of KRAS-cRAF.

Biochemical and biophysical research communications·2024
Same author

Preschool-age children maintain a distinct memory CD4<sup>+</sup> T cell and memory B cell response after SARS-CoV-2 infection.

Science translational medicine·2024
Same author

Beyond the genome: protecting the proteome may be the key to preventing skin aging.

European journal of dermatology : EJD·2024
Same author

[Type I interferon deficiency does not impair humoral immune response to SARS-CoV-2 vaccination].

Medecine sciences : M/S·2024

Our genome prioritizes species perpetuation, viewing post-reproductive diseases as evolutionarily irrelevant. However, manipulating genes like TP53 could enable future heritable disease avoidance.

Area of Science:

  • Evolutionary biology
  • Genetics
  • Cancer research

Background:

  • The human genome is optimized for species propagation, not individual longevity.
  • Evolutionary pressures typically cease after the reproductive phase of an organism.
  • Diseases manifesting post-reproduction are not a primary focus of natural selection.

Purpose of the Study:

  • To explore the concept of the soma as a disposable vehicle for germline propagation.
  • To investigate the potential for 'rebelling' against germline genetic programming.
  • To examine cancer and the TP53 gene as a model for understanding and potentially overcoming evolutionary constraints on health.

Main Methods:

  • Review of evolutionary theory, particularly Richard Dawkins' concept of the selfish gene.

Related Experiment Videos

  • Analysis of cancer as a disease of aging and post-reproductive decline.
  • Examination of existing research on the TP53 gene and its role in cancer latency.

    • Main Results:

    • The genome functions to ensure its own perpetuation through successive generations.
    • Cancer serves as a potential example of a disease that could be targeted by manipulating the germline.
    • Studies in mice indicate that increasing TP53 gene copies can extend cancer latency.

    Conclusions:

    • Humans are currently 'disposable somas' serving the germline genome.
    • Future interventions may involve germline manipulation for heritable disease prevention.
    • The TP53 gene and cancer provide a potential paradigm for future therapeutic strategies.